Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Active not recruiting × Taxes × Clear all

Phase

Phase 2 35 Phase 3 15 Phase 1 12 Phase 1/2 6 Phase 2/3 3 Phase NA 2 Phase 4 1

Status

Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Non-Small Cell Lung Cancer Metastatic 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 5 Dexamethasone 3 Cisplatin 3 human papillomavirus vaccine, L1 type 16, 18 2 adacel 2 Tobacco Use Cessation Devices 2 Tetanus Toxoid 2 Prednisone 2 Papillomavirus Vaccines 2 Letrozole 2 Diphtheria-Tetanus-acellular Pertussis Vaccines 2 Diphtheria Toxoid 2 Denosumab 2 Carboplatin 2 Cannabidiol 2 Atorvastatin 2 Anesthesia, Epidural 2 xiapex 1 venetoclax 1 trametinib 1 tirbanibulin 1 tenofovir alafenamide 1 sofosbuvir-velpatasvir drug combination 1 ruxolitinib 1 ribociclib 1 rasburicase 1 pembrolizumab 1 pasireotide 1 nimotuzumab 1 mogamulizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05689671 2026-03-10

ANTELOPE

Charite University, Berlin, Germany

Phase 4 Active not recruiting

Non-Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡